Formula Wellness Partners with Bella Excellence to Elevate Wellness and Aesthetics in Tampa Bay

January 21, 2025 12:00 PM

Formula Wellness, a pioneer in personalized health and wellness solutions, is excited to announce a strategic partnership with Bella Excellence, a renowned medical spa in Tampa Bay celebrated for its expertise in advanced aesthetics and wellness. This collaboration will enhance Bella Excellence's ability to provide integrated health solutions, building on their established wellness offerings to deliver a more comprehensive client experience.At...

Read more

How One Distribution Site Reduces an Estimated 60 Metric Tons of Packaging Annually

January 21, 2025 11:00 AM

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, revolutionized its approach to packaging sustainability with its SMASH Packaging initiative. Building on the program's success since its original launch in 2019, the company introduced SMASH 2.0 last year. SMASH 2.0 is an updated packaging sustainability framework to optimize its implementation across the organization, with new targets set for...

Read more

IntusCare Announces Marcus Whitney as New Board Member, Strengthening Leadership and Expertise in Healthcare Innovation

January 21, 2025 10:30 AM

IntusCare, a technology leader in the PACE market, today announced the addition of Marcus Whitney, founder and managing partner of Jumpstart Health Investors (JHI), to its Board of Directors. A healthcare venture capitalist, author, and thought leader, Whitney brings his extensive expertise in healthcare innovation and strategic investments and marks a significant step forward in the company's commitment to improving healthcare outcomes for...

Read more

2025 Top-Rated Behavioral Health Technology Vendors Announced: Black Book Research Recognizes the Best in Client Satisfaction and Innovation

January 21, 2025 10:00 AM

Black Book Research, a leading independent market research firm in healthcare, announces the 2025 Top Client-Rated Vendors in Behavioral Health Technology. This year's report highlights the most innovative vendors in the field, recognized for their exceptional client satisfaction and comprehensive service delivery. Based on feedback from 1,308 behavioral health professionals - including psychologists, therapists, addiction specialists, social...

Read more

Water Tower Research Spotlights Ainos' AI Nose Programs and Strategic Milestones for 2025

January 21, 2025 10:00 AM

SAN DIEGO, CA / ACCESS Newswire / January 21, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer of digiting scent and low-dose interferon therapeutics, today announced that Water Tower Research ("WTR") has published a report projecting increased visibility for the Company's transformative AI Nose programs. The report emphasizes anticipated progress for AI Nose across multiple sectors, including robotics, smart...

Read more

New Horizons Medical Appoints Dr. Ximena Sanchez as Chief Medical Officer (CMO)

January 21, 2025 9:55 AM

New Horizons Medical (NHM), a leader in healthcare for dually diagnosed patients with Substance Use Disorders (SUD), behavioral, and mental health challenges, is thrilled to announce the appointment of Dr. Ximena Sanchez as its new Chief Medical Officer (CMO), effective January 15, 2025. Dr. Sanchez brings a wealth of experience to NHM, with a storied career spanning inpatient and outpatient settings. Her educational background is...

Read more

STR Behavioral Health Expands Addiction and Mental Health Treatment in Pennsylvania with Outpatient Clinic in Lancaster

January 21, 2025 9:30 AM

Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and eating disorder treatment services, is proud to announce the opening of STR Behavioral Health's newest outpatient center in Lancaster, Pennsylvania. This expansion addresses the increasing need for high-quality addiction and mental health treatment services in Pennsylvania and further strengthens the company's network of residential and outpatient treatment...

Read more

HGHmeds Brings Safety and Efficiency to the Expanding Global HGH Market

January 21, 2025 9:00 AM

HGHmeds, an online hormone clinic based out of Mexico, is stepping up to help address a growing global demand for Human Growth Hormone (HGH) treatments. As a licensed Mexican pharmacy that partners directly with top pharmaceutical manufacturers, HGHmeds can sell HGH medications at the lowest prices to a global customer base, increasing access to safe HGH products and providing an affordable alternative to buying these types of medications...

Read more

PharmaCord Announces Appointment of Robert Truckenmiller as CEO

January 21, 2025 9:00 AM

PharmaCord LLC, a leading provider of patient services for the pharmaceutical industry, today announced the appointment of Robert Truckenmiller as Chief Executive Officer, effective January 31st, 2025. Truckenmiller has nearly 25 years of experience in the pharmaceutical industry, most recently as Senior Vice President, Head of U.S. Vaccines for GSK, a global biopharmaceutical company specializing in vaccines and specialty medicines.PharmaCord...

Read more

Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)

January 21, 2025 8:00 AM

The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary hyperhidrosis -If successful, the Companies may explore clinical development in additional indications -Xyngari™ with Daxxify® has the potential to be the first approved needle-free intradermal delivery of a botulinum toxin product -SAN DIEGO, CA and SOUTH SAN FRANCISCO, CA / ACCESS Newswire / January 21, 2025 / Dermata...

Read more

The 2025 Black Book of Behavioral Health IT Released: A Competitive Intelligence Report

January 21, 2025 8:00 AM

Black Book Research announces the release of its latest comprehensive resource, The 2025 Black Book of Behavioral Health IT. This 60-page technical guide provides a data-driven exploration of the rapidly evolving behavioral health information technology (BHIT) landscape. The report is now available for free download at https://blackbookmarketresearch.com/2025-black-book-of-behavioral-health-it with simple registration.A Comprehensive Technical...

Read more

Heidi Kling: Transforming Mental Health Care Through Advocacy and Action

January 21, 2025 8:00 AM

In an era where mental health challenges continue to rise, Heidi Kling has emerged as a pivotal figure driving transformation in the field. A renowned mental health advocate, therapist, and researcher, Kling's work bridges the gap between clinical expertise and systemic reform, fostering a more compassionate and accessible mental health landscape. Through her unwavering commitment to evidence-based practices and empathetic care,Kling is...

Read more

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

January 21, 2025 8:00 AM

FORT LAUDERDALE, FL / ACCESS Newswire / January 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs.The newly launched drugs are Olanzapine and Olanzapine ODT. Olanzapine...

Read more

AlzeCure Receives Abstract Acceptance at Alzheimer’s Congress AD/PD 2025 on NeuroRestore ACD856

January 21, 2025 4:20 AM

STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that an abstract with preclinical data on NeuroRestore ACD856 demonstrating its anti-inflammatory and immunomodulatory effects has been accepted for presentation...

Read more

BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities

January 21, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience company specializing in advanced drug delivery systems, is excited to announce a major milestone in its research and development journey. The company is transitioning its cutting-edge R&D activities to the Gen-Plus Contract Research and Development Organization (CRDO) in Munich, Germany, with operations scheduled to begin on March 1, 2025. This...

Read more

My Nursing Laboratory Introduces Essential Self-Care Tools for Healthcare Professionals

January 20, 2025 6:30 PM

Healthcare professionals dedicate themselves to serving their communities, often under immense pressure and emotional strain. My Nursing Laboratory (MNL) was created with these challenges in mind, providing support, self-care, and motivation tailored specifically for nurses and other essential workers.My Nursing Laboratory (MNL) Affirmation CardsMNL was created by healthcare professionals who understand the challenges of the field firsthand. The...

Read more

New Open-Source GMP Platform Now Available to Pharma Manufacturers

January 20, 2025 10:00 AM

A leading global pharmaceutical company has launched the open-source Data Computation Platform (DCP), a GMP- compliant solution designed for pharmaceutical manufacturers. The platform offersreal-time monitoring, process optimization, and batch analysis, improving efficiency and compliance." The launch of DCP marks a major step forward for the pharmaceutical industry. The platform is highly useful and inspiring, empowering organizations to...

Read more

Remicade Biosimilar Market to Reach USD 4.01 Billion By 2035 At a 5.4% CAGR, Driven By Rising Demand For Cost-Effective Autoimmune Treatments | FMI

January 20, 2025 9:00 AM

The global remicade biosimilar market is projected to expand significantly between 2025 and 2035, with a market size growing from USD 2.32 billion in 2025 to USD 4.01 billion in 2035, at a robust compound annual growth rate (CAGR) of 5.4%. The market is primarily driven by the increasing prevalence of autoimmune diseases, the high cost of branded biologics, and the growing adoption of biosimilars as cost-effective alternatives.Biosimilars,...

Read more

Ethema to Present at Microcap Conference in Atlantic City on January 28-30, 2025

January 20, 2025 9:00 AM

Ethema Health Corporation (OTCPINK:GRST) ("Ethema" "GRST" or the "Company"), is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.Ethema's management team will deliver a corporate presentation and engage in one-on-one meetings with institutional and...

Read more

Bay County Medical Care Facility Announces Opening of Onsite Dialysis Den

January 20, 2025 8:00 AM

Bay County Medical Care Facility, a leading skilled nursing facility, is proud to announce the grand opening of its state-of-the-art onsite Dialysis Den. This innovative facility will provide essential dialysis services to residents, enhancing their quality of care, convenience, and overall well-being.The Dialysis Den will be operated in partnership with Heritage Dialysis, a highly respected provider known for its commitment to patient care and...

Read more